נובולוג Stock: price and insider trades · Israel
נובולוג: what insiders have been doing
נובולוג is a listed company. Its directors and officers file their transactions with TASE (ISA). Between 18 October 2025 and 18 October 2026, 13 insiders published 27 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
No insider has bought נובולוג shares on the open market in the past twelve months.
For context, the typical company on the same exchange (median of 530 companies) published 14 filings over the same period, against 27 filings here.
These figures are compiled from regulatory filings published by TASE (ISA). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 2,369,491 sharesShareXTAETASE:1677:6610:1140151:2026-09-30
- 602,054 sharesShareXTAETASE:1677:949:1140151:2026-09-30
- 229,382,772 shares57.5% of flowShareXTAETASE:1677:13273:1140151:2026-08-09
- 40,024,466 shares26.4% of flowShareXTAETASE:1677:8093:1140151:2026-08-05
- 176,735 shares100.0% of flowShareXTAETASE:1677:12598:1140151:2026-08-05
- 3,796,647 shares22.8% of flowShareXTAETASE:1677:7092:1140151:2026-08-04
- 170,373,654 shares42.5% of flowShareXTAETASE:1677:13273:1140151:2026-08-05
- 10 sharesShareXTAETASE:1677:12598:1140151:2026-06-30
- 2,146,430 shares50.3% of flowShareXTAETASE:1677:6610:1140151:2026-06-30
- 5,063,939 shares29.8% of flowShareXTAETASE:1677:7092:1140151:2026-06-30
- 53,519,174 shares49.8% of flowShareXTAETASE:1677:7568:1140151:2026-06-30
- 57,897,339 shares37.8% of flowShareXTAETASE:1677:8093:1140151:2026-06-30
- 1,042,077 shares46.9% of flowShareXTAETASE:1677:949:1140151:2026-06-30
- 8,267,243 sharesShareXTAETASE:1677:13394:1152289:2023-09-14
- 2,317,915 sharesShareXTAETASE:1677:5532:1217751:2025-02-16
- 13,158 sharesShareXTAETASE:1677:12598:1140151:2026-03-31
- 136,381,798 shares100.0% of flowShareXTAETASE:1677:13273:1140151:2023-01-15
- 7,570 sharesShareXTAETASE:1677:13394:1140151:2023-07-01
- 32,718,243 shares100.0% of flowShareXTAETASE:1677:6540:1140151:2023-12-31
- 71,202,672 shares100.0% of flowShareXTAETASE:1677:6608:1140151:2024-06-30
- 2,263,351 shares49.7% of flowShareXTAETASE:1677:6610:1140151:2026-03-31
- 8,432,924 shares47.4% of flowShareXTAETASE:1677:7092:1140151:2026-03-31
- 57,419,174 shares50.2% of flowShareXTAETASE:1677:7568:1140151:2026-03-31
- 200 sharesShareXTAETASE:1677:769:1140151:2025-12-31
- 1,158,563 shares53.1% of flowShareXTAETASE:1677:949:1140151:2026-03-31
25 of 27 declarations
About נובולוג
Novolog is a publicly traded company on the Tel Aviv Stock Exchange, specializing in the distribution of pharmaceutical products and medical devices. It focuses on improving access to healthcare in Israel.